Search by Drug Name or NDC

    NDC 24208-0411-05 Brimonidine Tartrate 2 mg/mL Details

    Brimonidine Tartrate 2 mg/mL

    Brimonidine Tartrate is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is BRIMONIDINE TARTRATE.

    Product Information

    NDC 24208-0411
    Product ID 24208-411_50ab3851-8101-408a-885b-13f78cd0e031
    Associated GPIs 86602020102010
    GCN Sequence Number 027882
    GCN Sequence Number Description brimonidine tartrate DROPS 0.2 % OPHTHALMIC
    HIC3 Q6G
    HIC3 Description MIOTICS AND OTHER INTRAOCULAR PRESSURE REDUCERS
    GCN 36281
    HICL Sequence Number 011786
    HICL Sequence Number Description BRIMONIDINE TARTRATE
    Brand/Generic Generic
    Proprietary Name Brimonidine Tartrate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Brimonidine Tartrate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION/ DROPS
    Route OPHTHALMIC
    Active Ingredient Strength 2
    Active Ingredient Units mg/mL
    Substance Name BRIMONIDINE TARTRATE
    Labeler Name Bausch & Lomb Incorporated
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA076260
    Listing Certified Through 2024-12-31

    Package

    NDC 24208-0411-05 (24208041105)

    NDC Package Code 24208-411-05
    Billing NDC 24208041105
    Package 1 BOTTLE, DROPPER in 1 CARTON (24208-411-05) / 5 mL in 1 BOTTLE, DROPPER
    Marketing Start Date 2003-05-28
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.80466
    Pricing Unit ML
    Effective Date 2024-02-21
    NDC Description BRIMONIDINE 0.2% EYE DROP
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis